The Latest Cardiac and Vascular News
Former chief medical officer of MyoKardia to lead clinical development at Renovacor PHILADELPHIA and BOSTON, June 02, 2021 (GLOBE NEWSWIRE) — Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology company developing adeno-associated virus (AAV)‑based gene therapies for devastating cardiovascular and central nervous system (“CNS”) diseases resulting from BAG3 gene variants, today announced the appointment […]
SOUTH SAN FRANCISCO, Calif., June 01, 2021 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on May 31, 2021 it granted stock options to purchase an aggregate of 49,500 shares of common stock to eight new employees whose employment commenced in May 2021 as a material inducement to […]
President and CEO Michael Coyle Steps Down Due to Personal Matters Douglas Devine to Serve as Interim CEO While Search for Permanent CEO is Conducted SAN FRANCISCO, June 01, 2021 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac […]
SANTA CLARA, Calif.–(BUSINESS WIRE)–HD Medical, Inc., the leader in cardiovascular disease (CVD) detection, today announces it has appointed Shaun Setty, MD, as its Chief Medical Officer (CMO). Dr. Setty is a cardiothoracic surgeon in Los Angeles, CA, with over 13 years of experience in pediatric and adult congenital cardiac surgery. […]
Further local deals are expected to take place in the course of the year LONDON, United Kingdom – ( BUSINESS WIRE ) – LivaNova PLC (NASDAQ: LIVN), a leader in medical technology and innovation, announced today that it has completed the initial completion of the divestment of its heart valve business (HV) to Gyrus […]
The First In Human implantation of the ICOMS FLOWMAKER® is assured following this financing BORDEAUX, France–(BUSINESS WIRE)–FineHeart S.A, a preclinical medical device company that has developed the ICOMS FLOWMAKER®, an Implantable Cardiac Output Management System designed to address the unmet need of patients suffering from severe heart failure, today announced the […]
Share Offering Over-subscribed JERUSALEM, June 1, 2021 /PRNewswire/ — VOTIS Subdermal Imaging Technologies, Ltd. announced today that it has raised US$2.5 million in a private placement of equity to a consortium of investors in Israel, Italy, the UK, and the US. Proceeds are being used to complete development of the company’s suite of medical devices and […]
VALHALLA, N.Y., June 01, 2021 (GLOBE NEWSWIRE) — Retia Medical, an innovator in hemodynamic monitoring that helps clinicians guide care to prevent complications from high-risk surgeries such as heart attacks, strokes, and acute kidney injuries, today announced that Bernd Saugel, MD, EDIC joins other distinguished clinicians on Retia Medical’s Clinical […]
DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (NASDAQ: ABMD) has acquired preCARDIA, developer of a proprietary catheter and controller that will complement Abiomed’s product portfolio to expand options for patients with acute decompensated heart failure (ADHF). The preCARDIA system is uniquely designed to rapidly treat ADHF-related volume overload by effectively reducing cardiac filling pressures and […]
− APOLLO-B is the Industry’s Furthest Progressed Randomized, Double-Blind, Placebo-Controlled Pivotal Study of an Investigational TTR Silencer in Hereditary and Wild-type ATTR Amyloidosis with Cardiomyopathy − − Topline Results Expected in Mid-2022 − CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it has achieved […]
